Min Lu

3.0k citations
32 papers · 1.4k · 2 hit papers · h-index 14

Impact in

Papers in

    • Epigenetics and DNA Methylation 4
    • Cancer-related gene regulation 2
    • Wnt/β-catenin signaling in development and cancer 2
    • Cancer, Hypoxia, and Metabolism 7

Min Lu

32 papers receiving 1.4k citations

Min Lu's Hit Papers

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial 2023 · 123 citations
1230+2+4Years since publication100200300400

Peers

Min Lu
Comparison fields: 5 of 115
  • Cancer Research 300
  • Genetics 171
  • Oncology 289
  • Aging 20
  • Biotechnology 97
Replace Shafiq U. Ahmed with:
Shafiq U. Ahmed United Kingdom
Wen-Mei Yu United States
Sung Choe United States
Jermaine Goveia Belgium
Alpaslan Tasdogan Germany
Sharanya Sivanand United States
Su Yeon Lee South Korea
Timothy G. Pestell United States
Michael Milyavsky Israel
Oona Delpuech United Kingdom
Min Lu relative to Shafiq U. Ahmed United Kingdom Shafiq U. Ahmed's profile →
Citations per field
00.5×2.9×
Shafiq U. Ahmed · 1×
Citations per year

Countries citing papers authored by Min Lu

Since Specialization
Citations

This map shows the geographic impact of Min Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Lu more than expected).

Fields of papers citing papers by Min Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Lu. The network helps show where Min Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Min Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Min Lu Line = papers co-authored together Min Lu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dietary methionine influences therapy in mouse cancer models and alters human metabolism
Hit paper breakdown →
2019454
2 2002227
3 2004142
4
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
Hit paper breakdown →
2023123
5 201892
6 201669
7 201739
8 201938
9 201829
10 202229
11 202224
12 202024
13 201923
14 201622
15 201813
16 202011
17 20218
18 20217
19 20116
20 20215

About Min Lu

Min Lu is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 1.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (2 papers), Adult and Continuing Education Topics (2 papers), Cancer-related gene regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Cancer Research (300 citations), Genetics (171 citations), Oncology (289 citations), Aging (20 citations) and Biotechnology (97 citations). Min Lu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include David S. Hsu, Stephen H. Settle, David W. Threadgill, Reade B. Roberts, Robert J. Coffey, M. Kay Washington, Sydney M. Sanderson, Jason W. Locasale, John P. Richie and Gene P. Ables. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Neuro-Oncology, Nature Communications and Cancer Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact